Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acelyrin Inc (NQ: SLRN )

4.339 -0.181 (-4.00%)
Streaming Delayed Price Updated: 1:17 PM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Acelyrin Inc

< Previous 1 2 3 4 5 6 Next >
The Surprising Acelyrin News That Sent Rival MoonLake, A Top 1% Stock, Soaring 19%
The companies are both working on treatments for a rare skin disease. 
Via Investor's Business Daily
Why Is Acelyrin (SLRN) Stock Down 58% Today?
Acelyrin (SLRN) stock is falling hard on Tuesday after the biopharma company announced lackluster clinical trial results. 
Via InvestorPlace
Why Is Skin Disorders Focused Acelyrin Stock Trading Lower Today?
Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe  
Via Benzinga
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day off with a breakdown of the biggest pre-market stock movers worth watching on Tuesday morning! 
Via InvestorPlace
The Week In Charts - More 0DTE. Plus How To Enter A Stock
Give an IPO five days to see how the charts settle before jumping in. 
Via Talk Markets
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
From Acelyrin, Inc.
Via GlobeNewswire
ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Acelyrin, Inc.
Via GlobeNewswire
The Truth About IPO Investing
When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and  
Via Benzinga
ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
One key metric to look for in a stock is an 80-plus Relative Strength Rating. ACELYRIN stock hit that mark on Tuesday, with a jump to 81. 
Via Investor's Business Daily
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Acelyrin (SLRN) Q2 2023 Earnings Call Transcript
SLRN earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
From Acelyrin, Inc.
Via GlobeNewswire
ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023
From Acelyrin, Inc.
Via GlobeNewswire
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer
From Acelyrin, Inc.
Via GlobeNewswire
3 Must-Watch Stocks as IPO Valuations Skyrocket
The IPO market has come back to life, leading to outsized investor interest in these must-watch stocks in recent weeks. 
Via InvestorPlace
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 25 points on Monday. Following the market opening Monday, the Dow traded up 0.08% to 33,753.64 while the NASDAQ rose... 
Via Benzinga
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
From Acelyrin, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 29 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 212 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 199 companies reached new 52-week lows. 
Via Benzinga
J&J's Kenvue Jumps 20% In Market Debut
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known... 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.